Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
177.00
171.00
96.61%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
177.00
171.00
96.61%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-13.00
-9.00
-69.23%
Raw Materials Consumed
282.00
95.00
187.00
196.84%
Power & Fuel Cost
4.00
5.00
-1.00
-20.00%
Employee Cost
12.00
31.00
-19.00
-61.29%
Operating Expenses
10.00
0.00
10.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
3.00
2.00
66.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
1.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
127.00
183.00
144.09%
Operating Profit (PBDIT) excl Other Income
37.00
49.00
-12.00
-24.49%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
38.00
50.00
-12.00
-24.00%
Interest
13.00
8.00
5.00
62.50%
Profit before Depriciation and Tax
25.00
42.00
-17.00
-40.48%
Depreciation
3.00
20.00
-17.00
-85.00%
Profit Before Taxation & Exceptional Items
21.00
21.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
21.00
0.00
0.00%
Provision for Tax
5.00
4.00
1.00
25.00%
Profit After Tax
15.00
17.00
-2.00
-11.76%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
80.00
-52.00
-65.00%
Profit Available for appropriations
44.00
98.00
-54.00
-55.10%
Appropriations
44.00
98.00
-54.00
-55.10%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
33.66
7.97
25.69
322.33%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023






